{"id":"W2971515944","doi":"10.1016/s2214-109x(19)30318-3","title":"World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions","year":2019,"lang":"en","type":"article","venue":"The Lancet Global Health","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":1175,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Cilag; NIHR Cambridge Biomedical Research Centre; Health and Social Care Research and Development Division; Daiichi Sankyo Company; European Research Council; Economic and Social Research Council; Irving Medical Center, Columbia University; Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Johnson and Johnson; National Institutes of Health; FONDATION ALZHEIMER; Hjartavernd; Medical Research Council Canada; Technische Universität München; Leids Universitair Medisch Centrum; Biotronik; Università degli Studi di Padova; Health Research Council of New Zealand; Cambridge University Hospitals; Capital Medical University; Rijksuniversiteit Groningen; Universität Heidelberg; Public Health Agency; Hirosaki University; South African Medical Research Council; Istituto Superiore di Sanità; Diabetes Australia; University of Oxford; Medical Research Council; Servier; Kidney Health Australia; Novo Nordisk UK Research Foundation; Singulex; University of Cambridge; Chief Scientist Office, Scottish Government Health and Social Care Directorate; Háskóli Íslands; British Heart Foundation; National Health and Medical Research Council; Shenzhen Center for Health Information; Kowa Company; UCLH Biomedical Research Centre; Medicines Company; Roche Products; University Hospitals Bristol NHS Foundation Trust; Lunds Universitet; Scottish Government; Pfizer UK; Deutsches Krebsforschungszentrum; Kowa Pharmaceutical Europe; Boston Scientific Corporation; Mylan; Regeneron Pharmaceuticals; Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences; Food and Drug Administration; Eli Lilly and Company; National Heart, Lung, and Blood Institute; Itä-Suomen Yliopisto; University of Minnesota; Universiteit Leiden; University of Glasgow; Amgen Foundation; Bristol-Myers Squibb; Teva Pharmaceutical Industries; Université Laval; Merck Sharp and Dohme; Novartis; Portland State University; Department of Health and Social Care; Daiichi Sankyo Europe; Yale University; Novo Nordisk; Medtronic; University College London; Wellcome Trust; World Health Organization; Sanofi; Deutsches Zentrum für Herz-Kreislaufforschung; Shahid Beheshti University of Medical Sciences; GlaxoSmithKline; Engineering and Physical Sciences Research Council; AstraZeneca; National Institute for Health and Care Research; NHS Blood and Transplant; Abbott Laboratories; Centers for Medicare and Medicaid Services; American Heart Association; Pfizer; International Society of Hypertension; Amgen; Boehringer Ingelheim; Aetna Foundation; Central Manchester University Hospitals NHS Foundation Trust; University of California, San Diego; Johns Hopkins University","keywords":"Disease; Medicine; Environmental health; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}